Japanese heart failure patients under the microscope: Vericiguat's Real-World impact revealed
NCT ID NCT06697353
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 33 times
Summary
This study looked at nearly 5,000 Japanese adults with chronic heart failure who started taking the drug vericiguat as part of their regular care. Researchers used hospital records to track outcomes like death, heart-related hospital stays, and how long patients stayed on the medication. The goal was to understand how vericiguat performs in everyday practice, not in a controlled trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.